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Phaeohyphomycosis refers to infections caused by the 
dematiaceous (darkly pigmented) fungi. These fungi en-
compass a large, heterogeneous group with a high num-
ber of genera, e.g. Alternaria, Bipolaris, Phialophora, 
Curvularia, and Exophiala. The fungi have pigmented 
hyphae due to melanin deposition in the cell wall of 
hyphae, conidia or both. They are found in decomposing 
plant debris, wood and soil, and inoculation of these 
opportunistic pathogens is possible through a disrupted 
skin barrier. Diseases caused by dematiaceous fungi are 
most common in the tropics/subtropics and are typically 
divided into chromoblastomycoses, eumycetoma and 
phaeohyphomycoses. Phaeohyphomycoses have dif-
ferent clinical manifestations, e.g. subcutaneous phaeo-
hyphomycosis. The initial subcutaneous cyst from this 
infection can ulcerate locally and/or become systemic and 
spread rapidly to renal, pulmonary and cerebral systems 
in an immunocompromised host.
We report here a case of subcutaneous phaeohypho-
mycosis caused by the dematiaceous fungus Alternaria 
dennisii (syn. Embellisia dennisii) in an immunocompro-
mised patient. To our knowledge, this is the first report 
of human disease associated with this particular species. 
CASE REPORT
An 85-year-old Caucasian woman of Scandinavian descent 
was referred to our department of dermatology due to a ra-
pidly spreading, ulcerated and inflamed lesion on her left leg. 
A lesion had appeared on her left lower leg 6 months prior to 
referral. Initially, the lesion appeared indolent, but during the 
last month it had grown more rapidly, was sore and had started 
to ulcerate. Prior treatment with topical corticosteroid had not 
abrogated growth. No further complaints were elicited during 
a systematic enquiry, specifically no fever, chills, night sweats, 
weight loss, eye complaints, coughing, wheezing, chest pain, 
or claudication. 
Prior medical history included long-standing hypertension, 
atrial fibrillation, diabetes mellitus, and muscle sarcoidosis 
without further organ involvement. There were no known 
prior skin diseases or allergies. Regular medications included 
olmesartan, metoprolol, warfarin, insulin, azathioprine, 100 
mg daily, and prednisolone, 10 mg daily.
Clinical examination revealed involvement of almost the 
entire medial aspect of the lower left leg with extensive 
exudative inflammation, punctuated black and haemorrhagic 
changes, and punched-out ulcers (Fig. 1). The skin was sore 
and oedematous. The remainder of the examination was unre-
markable. Histopathological examination of a skin biopsy prior 
to referral suggested fungal infection due to the presence of 
microabscesses and fungal elements. The patient was diagno-
sed with subcutaneous mycosis and was initially treated with 
oral terbinafine, 250 mg daily, because of a positive PCR for 
Trichophyton rubrum from the skin surface 3 months earlier. 
Histological examination of new skin biopsies showed Periodic 
Acid Schiff-positive fungal elements, darkly pigmented spores, 
and granulomas consistent with fungal infection. There was no 
sign of vasculitis, pyoderma or necrobiosis. Direct immunofluo-
rescence studies were negative. Microbiological examinations 
included a skin biopsy and scraping for microscopy and culture, 
and PCR analysis for dermatophytes. Routine blood work and 
blood cultures were unremarkable. PCR for dermatophytes from 
the skin samples were negative. Microscopy of blankophor-stai-
ned skin samples showed abundant hyphae and conidia. Samples 
were inoculated on Sabouraud agar, and the culture was positive 
after incubation for one week, showing grey-brown colonies 
with a dark-brown reverse. Microscopic examination showed 
brownish hyphae and after inoculation on cornmeal agar and 
rice and tween agar chains of club-shaped conidia. The conidia 
were multiseptate with transverse, longitudinal and oblique septa 
and some of the conidia had a terminal beak. The macroscopic 
and microscopic findings were consistent with Alternaria sp. 
A new skin biopsy and scraping were performed one week 
later, with the same macroscopic and microscopic findings. The 
isolate was sent to the Mycology reference laboratory in Bristol 
where the Alternaria sp. diagnosis was confirmed and subse-
quent nuclear ribosomal repeat region sequencing suggested 
Alternaria dennisii. Antifungal susceptibility testing showed 
in vitro susceptibility (based on normal ranges as there are no 
established breakpoints for Alternaria spp.) for amphotericin 
B, itraconazole, posaconazole and voriconazole.
Long-term treatment (over 6 months) with systemic itraco-
nazole, wound debridement and wound therapy was instituted 
and resulted in clearance of the offending pathogen. Follow-up 
5 months later with repeated wound swab and skin biopsy for 
microscopy, culture, and histopathological examination revea-
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Fig. 1. (a) Initial presentation of phaeohyphomycosis of the lower left 
leg. (b) The same patient 7 months after initiation of itraconazole therapy. 
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led no fungal infection. However, the course of wound healing 
was protracted by a rapidly deteriorating arterial perfusion 
pressure of both legs. 
DISCUSSION
To our knowledge this is the first report of human 
pathology due to Alternaria dennisii manifesting as 
subcutaneous phaeohyphomycosis. A review of the 
literature in PubMed, EMBASE and Google Scholar 
with MeSH, EmTree headings and free-text searches 
for Alternaria resulted in many publications of sub-
cutaneous phaeohyphomycosis caused by various 
fungal genera, but none in which a species diagnosis 
of Alternaria dennisii was made (as of 9 June 2015).
Alternaria is a ubiquitous mould with worldwide 
distribution in air, soil, and plants, and is well-known 
for its detrimental effects on crops. Certain species 
may cause airborne allergy and phaeohyphomycosis in 
humans (1, 2). The literature contains many references 
to opportunistic infections in immunocompromised 
patients, mostly organ-transplant recipients (3–5). 
Exophiala spp., Bipolaris spp. and Phialophora spp. are 
the organisms most commonly isolated in subcutaneous 
phaeohyphomycosis (6). The microbiological diagnosis 
of Alternaria rests on the macroscopic morphology and 
the characteristic microscopic findings. An exact spe-
cies diagnosis is difficult based solely on morphology 
and molecular methods, e.g. nucleic sequence analysis, 
are increasingly used. 
Our patient was immunocompromised due to diabe-
tes and treatment with azathioprine and prednisolone 
for muscular sarcoidosis. Prednisolone has also been 
highlighted previously as a risk factor in phaeohypho-
mycosis due to its undesirable effects on the skin barrier, 
especially increased skin fragility (7). Considering our 
patient’s medical history it is possible that the primary 
ulcer was trauma-related due to a fragile skin barrier and 
exacerbated by fungal infection. However, the patient 
denied any trauma. Differential diagnosis in these cases 
includes vasculitis, pyoderma gangrenosum, warfarin 
necrosis, cutaneous leishmaniasis, chromoblastomyco-
sis and eumycetoma. In our case sarcoidosis was also 
considered and excluded. 
There is no standard protocol for treating subcuta-
neous alternariosis, or indeed any of the phaeohypho-
mycoses (4). Surgical removal is generally the treatment 
of choice for small, single or non-numerous lesions (8). 
A combination of surgical excision with oral anti-
fungals is advised for larger or numerous lesions, as oral 
antifungals alone are usually insufficient. Itraconazole 
is usually the treatment of choice and long-term treat-
ment is generally recommended. The recommended 
treatment durations varies widely (from 3 to longer than 
12 months) and should be guided by clinical evaluation. 
Dose should be guided by regular serum concentration 
measurements of the chosen antifungal agent. 
Additional treatment options include the newer tria-
zoles, voriconazole and, posaconazole (3, 4, 9). Results 
of antifungal susceptibility testing may be helpful to 
determine the optimal antifungal agent. However, the 
evidence for in vitro/in vivo correlation is still sparse. 
Close follow-up is required and should include 
evaluation by culture and histopathology to ensure 
mycological cure.
Physicians should be aware of the possibility of 
deep mycotic skin infections in patients presenting 
with atypical ulcerating skin lesions, especially in im-
munocompromised individuals. This case reminds us 
that deep skin mycosis is most effectively diagnosed by 
correlating clinical and histopathological findings with 
macroscopic and microscopic examination of cultures. 
Furthermore, molecular methods are a valuable tool in 
the identification process.
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